Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.
暂无分享,去创建一个
P. Marynen | A. Hagemeijer | R. Sciot | M. Debiec‐Rychter | A. V. van Oosterom | M. Stul | J. Cools | H. Vranckx | N. Mentens | H. Prenen | H. Dumez | J. Roesel | B. Wasąg | M. Debiec-Rychter